Lipid Nanoparticles: Production, Characterization and Stability

What are lipid nanoparticles?  How are they structured?  How are they formed? What techniques are best to characterize them?  How great is their potential as drug delivery systems?  These questions and more are answered in this comprehensive and highly readable work on lipid nanoparticles. This work...

Full description

Bibliographic Details
Published in:Springer eBooks
Main Authors: Shah, Rohan (Author), Eldridge, Daniel (Author), Palombo, Enzo (Author), Harding, Ian (Author)
Corporate Author: SpringerLink (Online service)
Format: eBook
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2015.
Series:SpringerBriefs in Pharmaceutical Science & Drug Development,
Subjects:
Online Access:http://dx.doi.org/10.1007/978-3-319-10711-0
Перейти в каталог НБ ТГУ
LEADER 04233nam a22005535i 4500
001 vtls000557908
003 RU-ToGU
005 20210922085253.0
007 cr nn 008mamaa
008 170212s2015 gw | s |||| 0|eng d
020 |a 9783319107110  |9 978-3-319-10711-0 
024 7 |a 10.1007/978-3-319-10711-0  |2 doi 
035 |a to000557908 
039 9 |y 201702122135  |z Александр Эльверович Гилязов 
040 |a Springer  |c Springer  |d RU-ToGU 
050 4 |a RS380 
050 4 |a RS190-210 
072 7 |a TDCW  |2 bicssc 
072 7 |a MED072000  |2 bisacsh 
082 0 4 |a 615.19  |2 23 
100 1 |a Shah, Rohan.  |e author.  |9 462362 
245 1 0 |a Lipid Nanoparticles: Production, Characterization and Stability  |h electronic resource  |c by Rohan Shah, Daniel Eldridge, Enzo Palombo, Ian Harding. 
260 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2015.  |9 742221 
300 |a IX, 97 p. 30 illus., 18 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a SpringerBriefs in Pharmaceutical Science & Drug Development,  |x 1864-8118 
505 0 |a Introduction -- Composition and structure -- Production techniques -- Characterization -- Physicochemical stability. 
520 |a What are lipid nanoparticles?  How are they structured?  How are they formed? What techniques are best to characterize them?  How great is their potential as drug delivery systems?  These questions and more are answered in this comprehensive and highly readable work on lipid nanoparticles. This work sets out to provide the reader with a clear and understandable understanding of the current practices in formulation, characterization and drug delivery of lipid nanoparticles. A comprehensive description of the current understanding of synthesis, characterization, stability optimization and drug incorporation of solid lipid nanoparticles is provided. Nanoparticles have attracted great interest over the past few decades with almost exponential growth in their research and application. Their small particle size and subsequent high surface area make them ideal in many uses, but particularly as drug carrier systems. Nanoparticles made from lipids are especially attractive because of their enhanced biocompatibility imparted by the lipid. The work provides a detailed description of the types of lipid nanoparticles available (e.g. SLN, NLC, LDC, PLN) and how they range from imperfect crystalline to amorphous in structure. Current thoughts on where drugs are situated (e.g. in the core, or at the interface) and how this can be manipulated are discussed.  The many techniques for production, including the author's own variant of microwave heating, are fully discussed. Techniques for measuring arguably the most important characteristics of particle size and polydispersity are discussed, along with techniques to measure crystallinity, shape and drug capacity.  Finally, a full chapter on techniques for measuring stability, both in the absence and presence of drugs, is discussed, along with suggestions on how to optimize that stability. This work appeals to students of colloid science, practitioners of research into drug delivery and academics alike. 
650 0 |a medicine.  |9 566220 
650 0 |a Pharmaceutical technology.  |9 410704 
650 0 |a Biotechnology.  |9 303552 
650 0 |a Lipids.  |9 411742 
650 1 4 |a Biomedicine.  |9 566246 
650 2 4 |a Pharmaceutical Sciences/Technology.  |9 329108 
650 2 4 |a Biotechnology.  |9 303552 
650 2 4 |a Lipidology.  |9 312743 
700 1 |a Eldridge, Daniel.  |e author.  |9 462363 
700 1 |a Palombo, Enzo.  |e author.  |9 462364 
700 1 |a Harding, Ian.  |e author.  |9 462365 
710 2 |a SpringerLink (Online service)  |9 143950 
773 0 |t Springer eBooks 
830 0 |a SpringerBriefs in Pharmaceutical Science & Drug Development,  |9 447463 
856 4 0 |u http://dx.doi.org/10.1007/978-3-319-10711-0 
856 |y Перейти в каталог НБ ТГУ  |u https://koha.lib.tsu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=412098 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650) 
999 |c 412098  |d 412098